Novel Advances in Sustained and Controlled Release Drug Delivery Systems
A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Pharmaceutical Processes".
Deadline for manuscript submissions: closed (30 July 2021) | Viewed by 3483
Special Issue Editors
Interests: dug delivery; pharmaceutics; oral delivery; controlled and sustained release; pharmaceutical technology
Special Issues, Collections and Topics in MDPI journals
Interests: modern TCM preparations; micro/nanoparticle-based drug delivery systems; nanotherapy with phytomedicines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Sustained and controlled release drug delivery systems (SCRDDS) are designed to release a drug at a predetermined rate utilizing a tailor-made formulation or carrier. SCRDDS enables the slow release of a drug over an extended period after a single administration and maintains smooth levels of the drug in the blood for a long time, thus achieving the potentiation and attenuation of a medication. Considerable efforts have been focused on the development of SCRDDS to address the challenge of formulating drugs with significant biopharmaceutical/pharmacokinetic issues. The ultimate goal of developing SCRDDS is to regulate and control drug release in vitro and in vivo by designing rational dosage forms, to improve the curative effects of a drug. To date, there is still much room for the optimization of drug-release rates and sites.
This Special Issue “Novel Advances in Sustained and Controlled Release Drug Delivery Systems” aims to assemble the current advances in the development and application of SCRDDS to optimize the in vivo pharmacokinetic profiles and therapeutic actions of therapeutic drugs. Topics of interest include, but are not limited to:
- The rationales for sustained/controlled drug delivery;
- Techniques for sustained/controlled drug delivery;
- The design and evaluation of sustained/controlled drug-delivery systems;
- Applications of sustained/controlled drug-delivery systems.
Prof. Dr. Wei Wu
Dr. Xingwang Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sustained release
- controlled release
- drug delivery system
- dosage form
- formulation
- pharmacokinetics
